USFDA grants final nod to Caplin Point arm for Tranexamic Acid Injection Medical Dialogues Bureau21 July 2019 9:45 AM ISTTranexamic Acid Injection is a generic therapeutic equivalent version of Cyklokapron Injection, 100 mg/ml, of Pharmacia & Upjohn Company.Chennai:...
Teva Pharma wins USFDA approval for AirDuo Digihaler Inhalation Powder Medical Dialogues Bureau21 July 2019 9:30 AM ISTTeva Pharma's AirDuo Digihaler is indicated for the treatment of asthma in patients aged 12 years and older. AirDuo Digihaler is not used to relieve...
USFDA to review Sanofi isatuximab for treatment of multiple myeloma Medical Dialogues Bureau21 July 2019 9:15 AM ISTSanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
JnJ, Oklahoma to wrap up first trial over opioid crisis Medical Dialogues Bureau21 July 2019 9:00 AM ISTLawyers for Attorney General Mike Hunter and JnJ are set to deliver closing arguments in state court in Norman, Oklahoma following six weeks of...
Cipla gets 7 USFDA observations for Bengaluru API unit Medical Dialogues Bureau20 July 2019 12:05 PM ISTNew Delhi: Drug firm Cipla recently said the US health regulator conducted an inspection at its API manufacturing facility in Virgonangar, Bengaluru...
Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu Medical Dialogues Bureau20 July 2019 11:37 AM ISTIn a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit Medical Dialogues Bureau20 July 2019 9:52 AM ISTZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
Gufic Biosciences to launch Botulinum Neuromedicine in India Medical Dialogues Bureau20 July 2019 9:15 AM ISTMumbai: Gufic Biosciences Limited ("the Company") recently announced to launch Botulinum Neurotoxin in India in collaboration with USA based Company...
Bayer welcomes call for new trial in $2 billion glyphosate-based weedkiller case Medical Dialogues Bureau20 July 2019 9:00 AM ISTBayer had asked Judge Smith in June to overrule the jury verdict that its Roundup weedkiller caused the couple's non-Hodgkin's Lymphoma (NHL), arguing...
Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities Medical Dialogues Bureau19 July 2019 3:03 PM ISTNEW DELHI: The Union Cabinet Wednesday approved loans of Rs 330.35 crore to three state-owned pharma companies to help them clear employees'...
Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit Medical Dialogues Bureau19 July 2019 3:02 PM ISTAbbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump...
Novartis key multiple sclerosis drug Gilenya® approved by China NMPA Medical Dialogues Bureau19 July 2019 2:50 PM ISTBasel: Chinese National Medical Products Administration (NMPA) approved Novartis's drug Gilenya® for relapsing forms of multiple sclerosis (RMS) for...
